How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Equal Representation Act of 2025
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2026 · third_quarter · Q3
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Source: Senate LDA
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
New Era of Preventing End-Stage Kidney Disease Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
New Era of Preventing End-Stage Kidney Disease Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Initiatives to expand eligibility and utilization of the Medicare kidney disease education benefit. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Comments on the Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Comments on Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model. Comments on Organ Procurement Organizations (OPO) Conditions for Coverage Revision. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Initiatives to expand eligibility and utilization of the Medicare kidney disease education benefit. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Comments on the Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Comments on Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model. Comments on Organ Procurement Organizations (OPO) Conditions for Coverage Revision. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Medical Nutrition Therapy Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Improving Home Dialysis Act of 2026
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Kidney Disease Education Access Expansion Act of 2026
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Kidney Disease Education Access Expansion Act of 2026
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Initiatives to expand eligibility and utilization of the Medicare kidney disease education benefit. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Comments on the Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Comments on Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model. Comments on Organ Procurement Organizations (OPO) Conditions for Coverage Revision. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Initiatives to expand eligibility and utilization of the Medicare kidney disease education benefit. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Comments on the Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Comments on Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model. Comments on Organ Procurement Organizations (OPO) Conditions for Coverage Revision. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Medical Nutrition Therapy Act of 2026
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative. Outreach to CMS to request restoration of the collection of race and ethnicity data collection on Medicare beneficiaries with end stage renal disease. Comments on the Calendar Year Proposed Rules for the Medicare Physician Fee Schedule and Medicare Prospective Payment System.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
New Era of Preventing End-Stage Kidney Disease Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
New Era of Preventing End-Stage Kidney Disease Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Request to Reinstate Race & Ethnicity Data Collection in the ESRD Quality Reporting System. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative. Outreach to CMS to request restoration of the collection of race and ethnicity data collection on Medicare beneficiaries with end stage renal disease. Comments on the Calendar Year Proposed Rules for the Medicare Physician Fee Schedule and Medicare Prospective Payment System.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Request to Reinstate Race & Ethnicity Data Collection in the ESRD Quality Reporting System. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative. Outreach to CMS to request restoration of the collection of race and ethnicity data collection on Medicare beneficiaries with end stage renal disease. Comments on the Calendar Year Proposed Rules for the Medicare Physician Fee Schedule and Medicare Prospective Payment System.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to increase, improve and facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) and the Living Donor Protection Act (to be introduced). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. Activities in support of access to affordable, accessible health care. Comments on the Organ Procurement and Transplantation Networks Kidney Transplantation Committee regarding the Continuous Distribution (CD) of kidneys project. Comments on the Monitor Ongoing eGFR Modification Policy Requirements from the Organ Procurement and Transplantation Networks Minority Affairs Committee.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative. Outreach to CMS to request restoration of the collection of race and ethnicity data collection on Medicare beneficiaries with end stage renal disease. Comments on the Calendar Year Proposed Rules for the Medicare Physician Fee Schedule and Medicare Prospective Payment System.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Request to Reinstate Race & Ethnicity Data Collection in the ESRD Quality Reporting System. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative. Outreach to CMS to request restoration of the collection of race and ethnicity data collection on Medicare beneficiaries with end stage renal disease. Comments on the Calendar Year Proposed Rules for the Medicare Physician Fee Schedule and Medicare Prospective Payment System.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Request to Reinstate Race & Ethnicity Data Collection in the ESRD Quality Reporting System. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to increase, improve and facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) and the Living Donor Protection Act (to be introduced). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. Activities in support of access to affordable, accessible health care. Comments on the Organ Procurement and Transplantation Networks Kidney Transplantation Committee regarding the Continuous Distribution (CD) of kidneys project. Comments on the Monitor Ongoing eGFR Modification Policy Requirements from the Organ Procurement and Transplantation Networks Minority Affairs Committee.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Expanding Support for Living Donors Act of 2024
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." H.R. 10282, "Expanding Support for Living Donors Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments on National Institute of Minority Health and Health Disparities draft Strategic Plan. Comment on information collection request on Process Data for the Organ Donation and Transplantation Network (OPTN). Comments on revised HIV Organ Policy Equity Act Safeguards and Research Criteria.
Health Care Affordability Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." H.R. 10282, "Expanding Support for Living Donors Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments on National Institute of Minority Health and Health Disparities draft Strategic Plan. Comment on information collection request on Process Data for the Organ Donation and Transplantation Network (OPTN). Comments on revised HIV Organ Policy Equity Act Safeguards and Research Criteria.
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments to HRSA to update criteria for post-transplant graft survival metrics. Comments to HRSA on the HIV Organ Policy Equity (HOPE) Act of 2013 (P.L. 113-51)
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." H.R. 10282, "Expanding Support for Living Donors Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments on National Institute of Minority Health and Health Disparities draft Strategic Plan. Comment on information collection request on Process Data for the Organ Donation and Transplantation Network (OPTN). Comments on revised HIV Organ Policy Equity Act Safeguards and Research Criteria.
Living Donor Protection Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments to HRSA to update criteria for post-transplant graft survival metrics. Comments to HRSA on the HIV Organ Policy Equity (HOPE) Act of 2013 (P.L. 113-51)
Living Donor Protection Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." H.R. 10282, "Expanding Support for Living Donors Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments on National Institute of Minority Health and Health Disparities draft Strategic Plan. Comment on information collection request on Process Data for the Organ Donation and Transplantation Network (OPTN). Comments on revised HIV Organ Policy Equity Act Safeguards and Research Criteria.
Expanding Access to Diabetes Self-Management Training Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality. Comments on Medicare $2 Drug List Model RFI.
Expanding Access to Diabetes Self-Management Training Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Comments to CMS RFI on Alternative Payment Model Update and Increasing Organ Transplant Access (IOTA). Comments on CY 2025 Physican Fee Schedule and Medicare Shared Savings Program. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Treat and Reduce Obesity Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality. Comments on Medicare $2 Drug List Model RFI.
Treat and Reduce Obesity Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Comments to CMS RFI on Alternative Payment Model Update and Increasing Organ Transplant Access (IOTA). Comments on CY 2025 Physican Fee Schedule and Medicare Shared Savings Program. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Kidney PATIENT Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality. Comments on Medicare $2 Drug List Model RFI.
Kidney PATIENT Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Comments to CMS RFI on Alternative Payment Model Update and Increasing Organ Transplant Access (IOTA). Comments on CY 2025 Physican Fee Schedule and Medicare Shared Savings Program. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." H.R. 10282, "Expanding Support for Living Donors Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments on National Institute of Minority Health and Health Disparities draft Strategic Plan. Comment on information collection request on Process Data for the Organ Donation and Transplantation Network (OPTN). Comments on revised HIV Organ Policy Equity Act Safeguards and Research Criteria.
Living Organ Donor Tax Credit Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." H.R. 10282, "Expanding Support for Living Donors Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments on National Institute of Minority Health and Health Disparities draft Strategic Plan. Comment on information collection request on Process Data for the Organ Donation and Transplantation Network (OPTN). Comments on revised HIV Organ Policy Equity Act Safeguards and Research Criteria.
Restore Protections for Dialysis Patients Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality. Comments on Medicare $2 Drug List Model RFI.
Restore Protections for Dialysis Patients Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Comments to CMS RFI on Alternative Payment Model Update and Increasing Organ Transplant Access (IOTA). Comments on CY 2025 Physican Fee Schedule and Medicare Shared Savings Program. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality. Comments on Medicare $2 Drug List Model RFI.
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Comments to CMS RFI on Alternative Payment Model Update and Increasing Organ Transplant Access (IOTA). Comments on CY 2025 Physican Fee Schedule and Medicare Shared Savings Program. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Improving Access to Home Dialysis Act of 2024
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality. Comments on Medicare $2 Drug List Model RFI.
Improving Access to Home Dialysis Act of 2024
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Comments to CMS RFI on Alternative Payment Model Update and Increasing Organ Transplant Access (IOTA). Comments on CY 2025 Physican Fee Schedule and Medicare Shared Savings Program. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Living Donor Protection Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." H.R. 10282, "Expanding Support for Living Donors Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments on National Institute of Minority Health and Health Disparities draft Strategic Plan. Comment on information collection request on Process Data for the Organ Donation and Transplantation Network (OPTN). Comments on revised HIV Organ Policy Equity Act Safeguards and Research Criteria.
Living Donor Protection Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments to HRSA to update criteria for post-transplant graft survival metrics. Comments to HRSA on the HIV Organ Policy Equity (HOPE) Act of 2013 (P.L. 113-51)
Expanding Access to Diabetes Self-Management Training Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality. Comments on Medicare $2 Drug List Model RFI.
Expanding Access to Diabetes Self-Management Training Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Comments to CMS RFI on Alternative Payment Model Update and Increasing Organ Transplant Access (IOTA). Comments on CY 2025 Physican Fee Schedule and Medicare Shared Savings Program. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2026 · second_quarter · Q2
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Initiatives to expand access to home dialysis. H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2026 · first_quarter · Q1
Initiatives to expand access to home dialysis. Initiatives to expand eligibility and utilization of the Medicare kidney disease education benefit. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Comments on the Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Comments on Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model. Comments on Organ Procurement Organizations (OPO) Conditions for Coverage Revision. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2025 · fourth_quarter · Q4
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Initiatives to expand access to home dialysis. Request to Reinstate Race & Ethnicity Data Collection in the ESRD Quality Reporting System. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2025 · third_quarter · Q3
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative. Outreach to CMS to request restoration of the collection of race and ethnicity data collection on Medicare beneficiaries with end stage renal disease. Comments on the Calendar Year Proposed Rules for the Medicare Physician Fee Schedule and Medicare Prospective Payment System.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2025 · second_quarter · 2A
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2025 · second_quarter · Q2
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2025 · first_quarter · Q1
Activities to increase, improve and facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) and the Living Donor Protection Act (to be introduced). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. Activities in support of access to affordable, accessible health care. Comments on the Organ Procurement and Transplantation Networks Kidney Transplantation Committee regarding the Continuous Distribution (CD) of kidneys project. Comments on the Monitor Ongoing eGFR Modification Policy Requirements from the Organ Procurement and Transplantation Networks Minority Affairs Committee.
Initiatives to expand access to home dialysis. Medicare coverage of anti-obesity medications. Support for Medicare Part D Protected Classes. Access to Medicaid. Implementation of the Advancing American Kidney Health Initiative.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2024 · fourth_quarter · Q4
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." H.R. 10282, "Expanding Support for Living Donors Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments on National Institute of Minority Health and Health Disparities draft Strategic Plan. Comment on information collection request on Process Data for the Organ Donation and Transplantation Network (OPTN). Comments on revised HIV Organ Policy Equity Act Safeguards and Research Criteria.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2024 · third_quarter · Q3
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Comments to CMS RFI on Alternative Payment Model Update and Increasing Organ Transplant Access (IOTA). Comments on CY 2025 Physican Fee Schedule and Medicare Shared Savings Program. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2022 · second_quarter · Q2
Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021" to authorize Medicare reimbursement for staff-assisted home dialysis and for other purposes. Support for Protected Classes under Medicare Part D program. H.R. 1676, provide access to Medigap coverage for Medicare end-stage kidney disease patients under age 65. These Medicare beneficiaries do not have a guaranteed opportunity to purchase a Medigap policy. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. Legislation would expand coverage of nutrition therapy services to additional diseases and conditions and expand the types of medical providers for such services. S. 2203, H.R. 5804, Medicare Diabetes Self-Management Training Act. Expands coverage of diabetes outpatient self-management training. S. 2173, H.R. 2807, PREVENT DIABETES Act. Requires Medicare to offer its Diabetes Prevention Program in a virtual or online format. Support for Kidney Health Evaluation (KED) for patients with diabetes. S. 1512 and H.R. 2903, "CONNECT for Health Act." Expands coverage of telehealth services under Medicare. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act," to expand the types of health professionals permitted to provide weight loss management and counseling services under Medicare Part B and to include coverage of weight loss management drugs under Medicare Part D. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Participated in health community effort to urge HHS to expand Medicare coverage to include medically necessary dental treatments for solid organ transplant recipients and other vulnerable individuals. Submitted written comments on the Proposed Rule to implement the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 5534, S. 3353, 116th Congress) to provide Medicare Part B coverage of anti-rejection medications for kidney transplant recipients who lack private, group or other public health insurance coverage for these medications. Submitted comments on the Proposed Calendar Year 2023 Inpatient Prospective Payment System (IPPS) rule. Wrote individual Medicare Administrative Contractors (MACs) to request they align their policies to implement the routine and timely use of Cystatin C to assess kidney function.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2022 · first_quarter · Q1
Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021" to authorize Medicare reimbursement for staff-assisted home dialysis and for other purposes. Support for Protected Classes under Medicare Part D program. H.R. 1676, provide access to Medigap coverage for Medicare end-stage kidney disease patients under age 65. These Medicare beneficiaries do not have a guaranteed opportunity to purchase a Medigap policy. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. Legislation would expand coverage of nutrition therapy services to additional diseases and conditions and expand the types of medical providers for such services. S. 2203, H.R. 5804, Medicare Diabetes Self-Management Training Act. Expands coverage of diabetes outpatient self-management training. S. 2173, H.R. 2807, PREVENT DIABETES Act. Requires Medicare to offer its Diabetes Prevention Program in a virtual or online format. S. 1512 and H.R. 2903, "CONNECT for Health Act." Expands coverage of telehealth services under Medicare. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act," to expand the types of health professionals permitted to provide weight loss management and counseling services under Medicare Part B and to include coverage of weight loss management drugs under Medicare Part D. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Recommendations on the rulemaking process to implement the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 5534, S. 3353, 116th Congress) to provide Medicare Part B coverage of anti-rejection medications for kidney transplant recipients who lack private, group or other public health insurance coverage for these medications. Submitted comments on the Advanced Notice for Calendar Year 2023 for Medicare Advantage Capitation Rates and Medicare Part C and Part D Payment Policies.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2021 · fourth_quarter · Q4
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act to prohibit discrimination in the issuing, pricing, and benefits level of life, disability or long-term care insurance for living organ donors. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care in general and in chronic kidney disease detection, prevention, management and care. Expand patients access to telemedicine. Submitted comments on Healthy People 2030. Signed health coalition comments letter on HHS Strategic Plan for FY 2022-2026. Support for the Advanced Research Projects Agency for Health (ARPA-H) Prescription drug pricing and access. Affordable Care Act access and utilization. 21st Century Cures draft legislation.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2021 · third_quarter · Q3
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access, including S. 1512 and H.R. 2903, "CONNECT for Health Act." Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care in general and in chronic kidney disease detection, prevention, management and care. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act." Prescription drug pricing and access. Affordable Care Act access and utilization. 21st Century Cures draft legislation.
Support for Protected Classes under Medicare Part D program. H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021." Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2021 · second_quarter · Q2
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Letter of support for S. 596 and H.R. 1577, the Treat and Reduce Obesity Act. Letter of support for S. 1024 and H.R. 2255, the Healthcare Workforce Resiliency Act. Prescription drug pricing and access. Affordable Care Act access and utilization.
Support for Protected Classes under Medicare Part D program. Support for H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2021 · first_quarter · Q1
Support for Protected Classes under Medicare Part D program. Support for H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. Activities to address access and utilization of home dialysis. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers).
Initiatives to increase and facilitate organ donation and transplantation. Comments to HHS regarding Organ Procurement Organization Conditions for Coverage. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to address access and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Early detection and management of Chronic Kidney Disease, including recommendation to provide CKD screening in Federally Qualified Health Centers. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Prescription drug pricing and access. Affordable Care Act access and utilization.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2020 · fourth_quarter · Q4
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis, access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Initiatives related to ethnic, racial and social health disparities Prescription Drug Pricing and Access Management of the Affordable Care Act
Comments on proposed changes to the process for extending the period of authorized stay for certain nonimmigrant visa classifications (J-1).
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2020 · third_quarter · Q3
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model. Increased utilization of home dialysis and other home health benefits. Extension of Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353). Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Comments on Medicare Hospital Inpatient Prospective Payment System and Medicare and Medicaid Interoperability Programs Requirements. Comments on Medicare ESRD Prospective Payment System and Quality Incentive Program. Comments on Medicare Physician Fee Service and Quality Payment Program. Increased use of Kidney Discards for transplantation. Access of medications under Medicare Part D Protected Classes.
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis, access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Initiatives related to ethnic, racial and social health disparities Prescription Drug Pricing and Access Management of the Affordable Care Act
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2020 · second_quarter · Q2
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis and other home health benefits Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353) Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Comments on Proposed Rule for changes to Medicare Advantage (including enrollment of ESRD patients), Medicare prescription drug program, and Medicare Cost Plan Program Comments on Origin and Destination Requirements under the Ambulance Fee Schedule Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Support for H.R. 6971, Medical Nutrition Therapy Act
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis (including patients with acute kidney injury), access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Department of Health and Human Services KidneyX initiative Video conference discussion with HRSA Division of Transplantation to discuss various issues surrounding organ donation Comments on proposed expansion of reimbursement of travel and subsistence expenses associated with living organ donation Prescription Drug Pricing and Access Management of the Affordable Care Act
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2020 · first_quarter · Q1
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Early detection and management of Chronic Kidney Disease Department of Health and Human Services KidneyX initiative Comments on Organ Procurement Organization Conditions of Coverage for Outcomes Measures Comments on proposed revisions to living organ donor financial assistance Prescription Drug Pricing and Access Management of the Affordable Care Act
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353 Comments on the Advanced Notice for Medicare Advantage Capitation and Part C and Part D payments Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2019 · fourth_quarter · Q4
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534) Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Comments on proposed rule on ESRD Treatment Choices Model Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on interpretive guidance Conditions of Participation for organ transplant programs Comments on proposed revisions for organ procurement organization Conditions of Coverage outcomes measures
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Comments on Donation Service Areas for organ allocation Comments on Public Health Service Guidelines on organ allocation and utilization Prescription Drug Pricing and Access Reauthorization of the Patient-Centered Outcomes Research Institute Management of the Affordable Care Act Repeal and Replacement of the Affordable Care Act
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2019 · third_quarter · Q3
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Comments on proposed rule on ESRD Treatment Choices Model Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on interpretive guidance Conditions of Participation for organ transplant programs Comments on proposed revisions for organ procurement organization Conditions of Coverage outcomes measures
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality. Comments on Medicare $2 Drug List Model RFI.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments to HRSA to update criteria for post-transplant graft survival metrics. Comments to HRSA on the HIV Organ Policy Equity (HOPE) Act of 2013 (P.L. 113-51)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act to prohibit discrimination in the issuing, pricing, and benefits level of life, disability or long-term care insurance for living organ donors. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including supply change disruptions; prioritization for access to vaccination for dialysis patients and kidney transplant recipients; and, priority access to specific COVID-19 prescriptions. Comments on the Strategic National Stockpile. Healthy People 2030. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care and in chronic kidney disease detection, prevention, management and care. Activities included H.R. 7585, the Health Equity and Accountability Act (HEAA). H.R. 5030/S.2706, DIVERSE Trials Act to address clinical trails participation barriers by underrepresented patient populations. H.R. 7667, PDUFA reauthorization (support for clinical trial diversity provisions). Expand access to telemedicine. Support for limits on insulin prices for consumers. Prescription drug pricing and access. Affordable Care Act access and utilization.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act to prohibit discrimination in the issuing, pricing, and benefits level of life, disability or long-term care insurance for living organ donors. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including supply change disruptions; prioritization for access to vaccination for dialysis patients and kidney transplant recipients; and, priority access to specific COVID-19 prescriptions. Comments on the Strategic National Stockpile. Healthy People 2030. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care and in chronic kidney disease detection, prevention, management and care. H.R. 5030/S.2706, DIVERSE Trials Act to address clinical trails participation barriers by underrepresented patient populations. Expand access to telemedicine. Prescription drug pricing and access. Affordable Care Act access and utilization.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021" to authorize Medicare reimbursement for staff-assisted home dialysis and for other purposes. Support for Protected Classes under Medicare Part D program. H.R. 1676, provide access to Medigap coverage for Medicare end-stage kidney disease patients under age 65. These Medicare beneficiaries do not have a guaranteed opportunity to purchase a Medigap policy. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. Legislation would expand coverage of nutrition therapy services to additional diseases and conditions and expand the types of medical providers for such services. S. 2203, H.R. 5804, Medicare Diabetes Self-Management Training Act. Expands coverage of diabetes outpatient self-management training. S. 2173, H.R. 2807, PREVENT DIABETES Act. Requires Medicare to offer its Diabetes Prevention Program in a virtual or online format. S. 1512 and H.R. 2903, "CONNECT for Health Act." Expands coverage of telehealth services under Medicare. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act," to expand the types of health professionals permitted to provide weight loss management and counseling services under Medicare Part B and to include coverage of weight loss management drugs under Medicare Part D. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Request to expedite the rulemaking process following the 116th Congress enactment of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 5534, S. 3353) to provide Medicare Part B coverage of anti-rejection medications for kidney transplant recipients who lack private, group or other public health insurance coverage for these medications.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model. Increased utilization of home dialysis and other home health benefits. Extension of Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353). Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Increased use of Kidney Discards for transplantation.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE